Skip to main content


Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting
Quick Connect

News

Dr. Reddys Strategic collaboration with Industrial Promotion Services (IPS) to support the East African Combined Pharmaceutical Center (EACPC) in Kenya

Dr. Reddys Strategic collaboration with Industrial Promotion Services (IPS) to support the East African Combined Pharmaceutical Center (EACPC) in Kenya
Dr. Reddys Strategic collaboration with Industrial Promotion Services (IPS) to support the East African Combined Pharmaceutical Center (EACPC) in Kenya

We are thrilled to announce a strategic collaboration with Industrial Promotion Services (IPS) to support the East African Combined Pharmaceutical Center (EACPC) in Kenya. This partnership will play a key role in improving healthcare access across East Africa by providing affordable, high-quality medicines for Non-Communicable Diseases (NCDs) and Oncology. We will leverage our expertise to ensure the EACPC meets stringent global quality standards. Also, the new facility is being designed and constructed with a focus on environmental efficiency, following IFC EDGE certification standards. This collaborative effort aligns perfectly with our commitment to achieving hashtag#UniversalHealthCoverage (hashtag#UHC) and contributes directly to Sustainable Development Goal #3 (Good Health and Well-being). Together with IPS, we aim to positively impact over 200 million lives in East Africa by 2030.

Contact Us

Please fill in the following form and we'll get back to you shortly.

Disclaimer

No information in this catalog - including any reference to any product or service - constitutes an offer for sale, or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities. Products protected under valid patents in India are not available for commercial use but would be available for Section 107A purposes.